Vireo Growth Files S-4 for Planet 13 Merger: 5.16M Shares, $51.8M Deal Value
VREOF is trading near its 52-week low of $8.91 (5.3% above the low).
Summary
Vireo Growth's S-4 registers 5.16 million shares for its all-stock acquisition of Planet 13, valued at $51.8 million, with Planet 13 facing going-concern risk if the deal fails.
Key Events · M&A and Partnerships · VREOF
-
Merger Terms Quantified
Fixed exchange ratio of 0.015383618 Vireo Growth shares per Planet 13 share, implying issuance of 5,158,426 shares for 335,319,455 Planet 13 shares outstanding as of June 30, 2026.
-
Deal Value Established
Estimated purchase price of $51.8 million based on Vireo Growth's June 30, 2026 closing price of $10.04 per share.
-
Warrant Assumption
18,750,000 Planet 13 warrants will be assumed, exercisable for 288,443 Vireo Growth subordinate voting shares with adjusted exercise prices.
-
Going-Concern Risk Disclosed
Planet 13 has substantial doubt about its ability to raise financing to continue as a going concern if the merger is not completed.
Analysis · VREOF · Life Sciences
The S-4 registration statement quantifies the previously announced all-stock acquisition of Planet 13. Vireo Growth will issue approximately 5.16 million subordinate voting shares at a fixed exchange ratio of 0.015383618 per Planet 13 share, valuing the deal at roughly $51.8 million based on the June 30, 2026 closing price. The filing also discloses that Planet 13 faces substantial doubt about its ability to continue as a going concern if the merger fails, underscoring the strategic urgency. Planet 13's special committee and board unanimously recommend approval, and a fairness opinion from ATB Cormark supports the consideration. The deal remains subject to stockholder approval and cannabis regulatory consents in Nevada, Florida, and Illinois.
How filings like this one have moved
In the 30 days to Oct 9, 2026, 36.7% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VREOF was trading at $9.38 on OTC in the Life Sciences sector, with a market capitalization of approximately $483.9M. The 52-week trading range was $8.91 to $22.50. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.